scholarly journals Is Privacy Regulation Slowing Down or Enabling the Wide Adoption of Pervasive Systems? Panel Summary

2019 ◽  
Author(s):  
Claudio Bettini
Keyword(s):  
Privacy Regulation ◽  
Slowing Down ◽  
Pervasive Systems ◽  
Panel Summary

scholarly journals Is Privacy Regulation Slowing Down Research on Pervasive Computing?

Computer ◽  
2020 ◽  
Vol 53 (6) ◽  
pp. 44-52
Author(s):  
Claudio Bettini ◽  
Salil Kanhere ◽  
Marc Langheinrich ◽  
Archan Misra ◽  
Delphine Reinhardt
Keyword(s):  
Pervasive Computing ◽  
Privacy Regulation ◽  
Slowing Down

Pengaruh Inflasi, BI Rate, NPF, dan BOPO terhadap Profitabilitas Bank Umum Syariah di Indonesia

2018 ◽  
Vol 6 (1) ◽  
pp. 133-153
Author(s):  
Toufan Aldian Syah
Keyword(s):  
Banking Industry ◽  
External Factors ◽  
Coefficient Of Determination ◽  
Muslim Country ◽  
Internal Factors ◽  
Slowing Down ◽  
The World ◽  
Negative Effect ◽  
Test Correlation ◽  
The Ideal

Banking industry has a very important role in economic development in a country. Indonesia, which is the largest Muslim country in the world, certainly has the prospect of the development of Sharia Banking Industry is very good in the future. However, the development of Sharia Bank has been slowing down in recent years and the profitability of sharia comercial banking is still below the ideal value. This study aims to determine the internal factors and external factors that affect the profitability of Sharia Bank in the year of January 2012 until August 2017. The variables used in this study are ROA, Inflation, NPF, and BOPO. The data used is aggregate data of all Sharia Commercial Banks recorded at Bank Indonesia. Measurement of Statistic Description, F-Test, T-Test, Correlation Coefficient, Coefficient of Determination and Multiple Linear Regression using IBM SPSS 21 software. The results showed that significant negative effect of BI rate, NPF and BOPO was found, while Inflation variable showed negative but not significant. Overall, the above variables affect the ROA of 87.7%, while 12.3% is likely to be influenced by other factors.

Privacy after the Agile Turn

2017 ◽  
Author(s):  
Seda Gurses ◽  
Joris Vredy Jan van Hoboken
Keyword(s):  
Information Systems ◽  
Software Industry ◽  
Data Driven ◽  
Dynamic Nature ◽  
Privacy Regulation ◽  
Research And Practice ◽  
Production Processes ◽  
Regulatory Frameworks ◽  
Software And Hardware ◽  
New Challenges

Moving beyond algorithms and big data as starting points for discussions about privacy, the authors of Privacy After the Agile Turn focus our attention on the new modes of production of information systems. Specifically, they look at three shifts that have transformed most of the software industry: software is now delivered as services, software and hardware have moved into the cloud and software’s development is ever more agile. These shifts have altered the conditions for privacy governance, and rendered the typical mental models underlying regulatory frameworks for information systems out-of-date. After 'the agile turn', modularity in production processes creates new challenges for allocating regulatory responsibility. Privacy implications of software are harder to address due to the dynamic nature of services and feature development, which undercuts extant privacy regulation that assumes a clear beginning and end of production processes. And the data-driven nature of services, beyond the prospect of monetization, has become part of software development itself. With their focus on production, the authors manage to place known challenges to privacy in a new light and create new avenues for privacy research and practice.

Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions

2019 ◽  
Vol 19 (5) ◽  
pp. 368-381 ◽  
Author(s):  
Linh N.K. Tran ◽  
Ganessan Kichenadasse ◽  
Pamela J. Sykes
Keyword(s):  
Prostate Cancer ◽  
Valproic Acid ◽  
Androgen Receptor ◽  
Gene Fusion ◽  
Combination Therapies ◽  
Slowing Down ◽  
Castration Resistant ◽  
Local Pca ◽  
End Stage ◽  
Fusion Products

Prostate cancer (PCa) is the most frequent cancer in men. The evolution from local PCa to castration-resistant PCa, an end-stage of disease, is often associated with changes in genes such as p53, androgen receptor, PTEN, and ETS gene fusion products. Evidence is accumulating that repurposing of metformin (MET) and valproic acid (VPA) either when used alone, or in combination, with another therapy, could potentially play a role in slowing down PCa progression. This review provides an overview of the application of MET and VPA, both alone and in combination with other drugs for PCa treatment, correlates the responses to these drugs with common molecular changes in PCa, and then describes the potential for combined MET and VPA as a systemic therapy for prostate cancer, based on potential interacting mechanisms.

Sign in / Sign up

Export Citation Format

Share Document